EUVIMEDEUVIMED entdecken
Crossref

Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway

Yalin Zhu, Yi Gong, Yifei Wang, Zhengyu Jiang, Ying Yao, Xiaoyong Miao, Shuoer Wang, Yan Zhang, Jianping Cao

Cell Biology International · 2025

DOI: 10.1002/cbin.12251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Yalin Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Naval Medical Center, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Flurbiprofen, MAP Kinase Signaling System, Breast Neoplasms, Cell Movement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Youth Training Program of Naval Medical Center, National Natural Science Foundation of China, Military Medical Research Program of Naval Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flurbiprofen axetil is commonly utilized in clinical practice as one of the nonsteroidal anti‐inflammatory drugs (NSAIDs) and is included in multimodal analgesia regimens postbreast cancer surgery. Numerous NSAIDs have been studied for their potential to both promote and inhibit cancer. Given the variability in their effects on tumors, further investigation into the specific role of flurbiprofen axetil is warranted. Therefore, the primary objective of this study was to assess the impact of flurbiprofen axetil on basal‐like breast cancer (BLBC) metastasis and elucidate the underlying molecular mechanisms involved. The BLBC metastasis mouse model was established by caudal vein injection of tumor cells. The lung metastasis of breast cancer in mice and the effect of flurbiprofen axetil were assessed by in vivo bioluminescence imaging, hematoxylin and eosin staining and immunohistochemistry. In vitro, the results of flurbiprofen axetil on the proliferation, migration, and invasion of MDA‐MB‐231 human breast cancer cells and BT‐549 human breast cancer cells were assessed by colony formation assay and transwell assay. The effects of flurbiprofen axetil on several tumor metastasis‐related signaling pathway proteins were examined by western blot, and the reversal extent of the flurbiprofen axetil effect by Ro 67‐7476 (ERK phosphorylation agonist) was detected by transwell assay. The results showed that flurbiprofen axetil significantly inhibited BLBC lung metastasis in mice. Flurbiprofen axetil similarly inhibited breast cancer cell migration and invasion in vitro but did not affect their proliferation. Mechanistic investigations have revealed that flurbiprofen axetil exerts a noteworthy inhibitory influence on the MEK/ERK pathway while exhibiting no significant alteration in the expression of other pathway proteins intricately associated with epithelial–mesenchymal transition. In conclusion, the inhibitory effect of flurbiprofen axetil on BLBC metastasis is characterized by its selectivity in targeting the MEK/ERK signaling pathway rather than exerting a broad impact on the global signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlurbiprofenMAP Kinase Signaling SystemBreast NeoplasmsCell MovementLung NeoplasmsAnimalsFemaleHumansMiceCell Line, TumorCell ProliferationAnti-Inflammatory Agents, Non-SteroidalMice, Inbred BALB CMice, NudeNeoplasm Metastasis

Stichwörter der Autor:innen

EMTMEK/ERKbasal‐like breast cancerflurbiprofen axetilmetastasis

Substanzen

Flurbiprofenflurbiprofen axetilAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Anesthesiology, Naval Medical Center, Naval Medical University, Shanghai, China.
  • Changhai Hospital, Faculty of Anesthesiology, Naval Medical University, Shanghai, China.
  • Department of Anesthesiology, Naval Hospital of Eastern Theater, Zhoushan, China.
  • Department of Respiratory Diseases and Critical Medicine, Quzhou Hospital Affiliated to Wenzhou Medical University, Quzhou, Zhejiang, China.
  • Department of Respiratory Diseases and Critical Medicine, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Förderung

  • Youth Training Program of Naval Medical Center
  • National Natural Science Foundation of China
  • Military Medical Research Program of Naval Medical Center

Zitieren

APA

Zhu, Y., Gong, Y., Wang, Y., Jiang, Z., Yao, Y., Miao, X., Wang, S., Zhang, Y., & Cao, J. (2025). Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway. Cell Biology International. https://doi.org/10.1002/cbin.12251

Vancouver

Zhu Y, Gong Y, Wang Y, Jiang Z, Yao Y, Miao X, et al. Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway. Cell Biology International. 2025. doi:10.1002/cbin.12251

BibTeX
@article{Zhu2025,
  author = {Zhu, Yalin and Gong, Yi and Wang, Yifei and Jiang, Zhengyu and Yao, Ying and Miao, Xiaoyong and Wang, Shuoer and Zhang, Yan and Cao, Jianping},
  title = {Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12251}
}
Kostenlos starten →